We next examined BACH2 and PRDM1 gene expression in CD4+ and CD8+ T-cells and leukemic B-cells (CD19 + CD5+) from untreated CLL patients and age-matched HDs (> 50 years). This evidence concerns the gene CD19 and B-cell chronic lymphocytic leukemia.